Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari
  • Home
  • Events Calendar
  • Home
  • Events Calendar

Events Calendar

Upcoming Events

Upcoming events relevant to the therapy areas of our treatments:
▼Rezzayo (rezafungin) click for GB or NI prescribing information 
Flutiform (fluticasone propionate / formoterol) click for prescribing information
Webinar Cover Picture




Introducing REZZAYO® rezafungin, the first once weekly echinocandin....

Introducing REZZAYO® (rezafungin), the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 With a renowned faculty of Professor Oliver Cornely, Professor Tihana Bicanic and Professor Matteo Bassetti.



1. REZZAYO® (rezafungin). Summary of Product Characteristics. Napp 2024.



19:00-20:00 BST

  • Key challenges in the management of invasive candidiasis​
  • The data from the REZZAYO® clinical trial programme​
  • The potential benefits of REZZAYO® in the ICU, ward and for the outpatient
  • Q&A


Professor Tihana Bicanic, Professor Oliver Cornely, Professor Matteo Bassetti

Recordings from Past Events

Load More